stockmarketproxy
/
RMDNYSE,OTC SEC EDGAR

RESMED INC

Surgical & Medical Instruments & Apparatus·SAN DIEGO, CA·FY end 06/30·CIK 943819
OverviewFinancialsCompensationGovernanceInsidersFilings

Financials

5-year history · USD
MetricFY 2025FY 2024FY 2023FY 2022FY 2021Trend
Revenue$5.1B$4.7B$4.2B$3.6B$3.2B
Gross Profit$3.1B$2.7B$2.4B$2.0B$1.8B
Operating Income$1.7B$1.3B$1.1B$1.0B$903.7M
Net Income$1.4B$1.0B$897.6M$779.4M$474.5M
Operating CF$1.8B$1.4B$693.3M$351.1M$736.7M
Capex$89.9M$99.5M$119.7M$134.8M$102.7M
Free Cash Flow$1.7B$1.3B$573.6M$216.3M$634.0M
Buybacks$300.0M$150.0M———
Dividends——————
Gross Margin59.4%56.7%55.8%56.6%57.5%
Operating Margin32.7%28.2%26.8%28.0%28.3%
Net Margin27.2%21.8%21.3%21.8%14.8%
FCF Margin32.3%27.8%13.6%6.0%19.8%
R&D / Revenue6.4%6.6%6.8%7.1%7.0%
Effective Tax16.5%19.3%18.5%18.8%46.3%
Debt / Equity0.110.140.350.230.22
Buybacks / FCF18.1%11.5%———

Peer comparison

Surgical & Medical Instruments & Apparatus · 5 peers
CEO Pay Ratio
RMD
187:1
BSX
348:1
SYK
264:1
MMM
316:1
PODD
213:1
BAX
257:1
CEO total comp
RMD
$15M
BSX
$24M
SYK
$21M
MMM
$21M
PODD
$19M
BAX
$18M
Net Margin
RMD
27.2%
BSX
—
SYK
11.8%
MMM
13.0%
PODD
9.1%
BAX
-8.5%